ISR signs investment agreement with Singaporean company for development of inhaled covid-19 vaccine

Sweden-based ISR Immune System Regulation Holding AB (publ), which develops inhalation vaccines against Covid-19 has signed an investment agreement with Singapore Resources Development PTE. Ltd, the company announced in this press …

ISR signs investment agreement with Singaporean company for development of inhaled covid-19 vaccine Read More